首页> 外国专利> New antibiotic preparation method and platform system based on it

New antibiotic preparation method and platform system based on it

机译:新的抗生素制备方法和基于该方法的平台系统

摘要

An antibiotic preparation method, comprising the following steps: (1) determining selected targets of prokaryotic cells, eukaryotic cells, and viruses with phospholipid bilayer membranes as the basic structure of their cell membrane or envelope; (2) design a molecular structure of said new antibiotic according to the following general formula: ** Formula ** in which R is the recognition region, which specifically recognizes said targets or is combined with said targets and F is the region effector, which produces pharmaceutical effects on said targets, said pharmaceutical effects causing death; (3) establish a library of molecular structure of the recognition region, which comprises artificially preparing artificial substances that specifically recognize said targets as well as obtaining a molecular structure of these artificial substances; (4) establishing a library of molecular structure of the effector region, wherein said effector region comprises a bioactive substance that can form an ion channel or a pore in said phospholipid bilayer membranes; (5) design a recombinant molecular structure library based on said molecular structure libraries of the recognition and effector regions according to said general formula by means of structural adjustment, structural recombination and / or structural confirmation of the molecular structures of the effector region or recognition; (6) based on said library of recombinant molecular structure, preparing and verifying recombinants to obtain candidates for new antibiotics; and (7) explore candidates' compliance with the requirements as medicine to obtain new antibiotics; wherein said artificial substances are antibody mimetics designed according to the amino acid sequence of an immunoglobulin that can specifically recognize a unique substance in said targets.
机译:一种抗生素的制备方法,包括以下步骤:(1)以磷脂双层膜作为其细胞膜或被膜的基本结构,确定原核细胞,真核细胞和病毒的选择靶标; (2)根据以下通式设计所述新抗生素的分子结构:**式**其中R为识别区域,其特异性识别所述靶标或与所述靶标结合,F为区域效应子,对所述靶标产生药物作用,所述药物作用导致死亡; (3)建立识别区域分子结构的文库,包括人工制备能特异性识别所述靶标的人工物质以及获得这些人工物质的分子结构。 (4)建立效应子区域的分子结构文库,其中所述效应子区域包含可在所述磷脂双层膜中形成离子通道或孔的生物活性物质; (5)通过效应子区域或识别分子结构的结构调整,结构重组和/或结构确认,根据所述通式,根据识别和效应子区域的分子结构库设计重组分子结构库。 (6)基于所述重组分子结构文库,制备并验证重组子以获得新抗生素的候选对象; (7)探索候选人是否符合医学要求以获取新的抗生素;其中所述人工物质是根据免疫球蛋白的氨基酸序列设计的抗体模拟物,其可以特异性识别所述靶标中的独特物质。

著录项

  • 公开/公告号ES2686341T3

    专利类型

  • 公开/公告日2018-10-17

    原文格式PDF

  • 申请/专利权人 PROTEIN DESIGN LAB LTD.;

    申请/专利号ES20120854873T

  • 发明设计人 QIU XIAOQING;

    申请日2012-12-10

  • 分类号C07K19;A61K39/395;A61P31;C12N15/62;C12N15/63;

  • 国家 ES

  • 入库时间 2022-08-21 12:48:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号